chlordiazepoxide has been researched along with 1-(3-chlorophenyl)piperazine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Benjamin, D; Lal, H; Meyerson, LR | 1 |
| Bill, DJ; Dourish, CT; Fletcher, A; Grewal, SS; Shepherd, JK | 1 |
| Bilkei-Gorzó, A; Gyertyán, I | 1 |
| Barsvári, B; Haller, J; Levay, G; Leveleki, C; Mikics, E; Soproni, K; Sziray, N | 1 |
| Ginsburg, BC; Lamb, RJ | 1 |
7 other study(ies) available for chlordiazepoxide and 1-(3-chlorophenyl)piperazine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Chlordiazepoxide; Male; Mice; Mice, Inbred Strains; Models, Psychological; Pentylenetetrazole; Piperazines; Quinoxalines; Serotonin | 1990 |
Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Ondansetron; Piperazines; Posture; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists | 1994 |
Some doubts about the basic concept of hole-board test.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Chlordiazepoxide; Drug Evaluation, Preclinical; Environment; Lighting; Male; Pentylenetetrazole; Piperazines; Rats; Rats, Wistar; Serotonin Receptor Agonists | 1996 |
Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Haloperidol; Male; Models, Neurological; Motor Activity; Phobic Disorders; Piperazines; Rats; Rats, Wistar; Reproducibility of Results; Serotonin Receptor Agonists; Stress, Psychological | 2006 |
Drug effects on multiple and concurrent schedules of ethanol- and food-maintained behaviour: context-dependent selectivity.
Topics: Alcoholism; Amphetamines; Animals; Chlordiazepoxide; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Ethanol; Food; Male; Morphinans; Naltrexone; Piperazines; Rats; Rats, Inbred Lew | 2014 |